Eyenovia Inc (EYEN): Company is a conduit for drug delivery f...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	797
Boards Moderated	0
Alias Born	08/10/2011

jdlamont

Re: jdlamont post# 2

Monday, 04/29/2019 10:54:02 AM

Monday, April 29, 2019 10:54:02 AM

Company is a conduit for drug delivery for every topical eye care drug company in existence, and hence will be bought out.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent EYEN News

Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks • IH Market News • 03/18/2024 11:12:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 12:11:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:13:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:10:48 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/31/2024 01:13:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:59:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:24:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:54:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:53:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:55 PM
Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 12:23:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2023 09:17:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 12:19:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/25/2023 04:07:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 07:16:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 11:31:25 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 04:22:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:18:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 10:42:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 10:41:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 10:41:44 PM

More EYEN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover